PT Indo Acidatama Tbk (ISX:SRSN) Research & Development: Rp3,905 Mil (TTM As of Mar. 2026)


ISX:SRSN PT Indo Acidatama Tbk ISX:SRSN
86 GF Score
Price Rp69.00
GF Value Rp59.60
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is PT Indo Acidatama Tbk Research & Development?

PT Indo Acidatama Tbk ISX:SRSN -1.43% 86 Research & Development is Rp3,905 Mil as of Mar. 2026. GuruFocus rates ISX:SRSN with a GF Score™ of 86/100 and a GF Value™ of Rp59.60 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Indo Acidatama Tbk's Research & Development for the three months ended in Mar. 2026 was Rp285 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp3,905 Mil.

PT Indo Acidatama Tbk  (ISX:SRSN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Indo Acidatama Tbk Research & Development Related Terms

PT Indo Acidatama Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Indo Acidatama Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Indo Acidatama Tbk Research & Development Chart

PT Indo Acidatama Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,009.30 680.85 568.88 2,315.16 3,710.78

PT Indo Acidatama Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.68 108.42 1,833.89 1,677.78 284.94
ISX:SRSN
86GF Score
PT Indo Acidatama Tbk ISX:SRSN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Indo Acidatama Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp3,905 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp3,905 Mil mean?
PT Indo Acidatama Tbk (ISX:SRSN) has a Research & Development of Rp3,905 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Indo Acidatama Tbk and its competitors.
Is PT Indo Acidatama Tbk's Research & Development too high?
PT Indo Acidatama Tbk's current Research & Development is Rp3,905 Mil. Overall, PT Indo Acidatama Tbk has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Indo Acidatama Tbk's Research & Development compare to DOW?
PT Indo Acidatama Tbk's Research & Development of Rp3,905 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Indo Acidatama Tbk and its competitors. PT Indo Acidatama Tbk's current Research & Development is Rp3,905 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Indo Acidatama Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Indo Acidatama Tbk (ISX:SRSN) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp59.60, compared to a current price of Rp69.00 — trading 15.8% above its estimated fair value. The current Research & Development is Rp3,905 Mil. PT Indo Acidatama Tbk's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Indo Acidatama Tbk (ISX:SRSN), the current Research & Development is Rp3,905 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Indo Acidatama Tbk (ISX:SRSN) Overvalued in 2026?

Based on GuruFocus' analysis, PT Indo Acidatama Tbk stock appears to be overvalued. The current stock price of Rp69.00 is trading 15.8% above its estimated GF Value™ of Rp59.60. GuruFocus considers PT Indo Acidatama Tbk to be Modestly Overvalued.

Key valuation signals for ISX:SRSN:

  • Research & Development: Rp3,905 Mil
  • GF Value™: Rp59.60 vs. price of Rp69.00 (15.8% above fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the ISX:SRSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Indo Acidatama Tbk Business Description

Address Jalan Raya Perjuangan 88, Graha Kencana, 9th Floor-Suite A, Jakarta Barat, Jakarta, IDN, 11530
PT Indo Acidatama Tbk is an Indonesian-based company engaged in manufacturing ethanol. The company produces acetic acid, ethyl acetate, bio-organic fertilizers, methylated spirit, and carbonic acid gas. It operates business activity in segments such as Ethanol, Acetic Acid, and Others. The fertilizers of the company are marketed under the brand names Pomi, Randex, Beka, and Alfinas. The company earns the majority of its revenue from the Ethanol segment.
86GF Score

Get the complete analysis for ISX:SRSN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp69.00
Price
Rp59.60
GF Value